Literature DB >> 31383769

Separation of Acute Desensitization and Long-Term Tolerance of µ-Opioid Receptors Is Determined by the Degree of C-Terminal Phosphorylation.

Seksiri Arttamangkul1, Emily R Leff1, Omar Koita1, William T Birdsong1, John T Williams2.   

Abstract

Phosphorylation of sites on the C terminus of the μ-opioid receptor (MOR) results in the induction of acute desensitization that is thought to be a precursor for the development of long-term tolerance. Alanine mutations of all 11 phosphorylation sites on the C terminus of MORs almost completely abolished desensitization and one measure of tolerance in locus coeruleus neurons when these phosphorylation-deficient MORs were virally expressed in MOR knockout rats. In the present work, we identified specific residues that underlie acute desensitization, receptor internalization, and tolerance and examined four MOR variants with different alanine or glutamate mutations in the C terminus. Alanine mutations in the sequence between amino acids 375 and 379 (STANT-3A) and the sequence between amino acids 363 and 394 having four additional alanine substitutions (STANT + 7A) reduced desensitization and two measures of long-term tolerance. After chronic morphine treatment, alanine mutations in the sequence between 354 and 357 (TSST-4A) blocked one measure of long-term tolerance (increased acute desensitization and slowed recovery from desensitization) but did not change a second (decreased sensitivity to morphine). With the expression of receptors having glutamate substitutions in the TSST sequence (TSST-4E), an increase in acute desensitization was present after chronic morphine treatment, but the sensitivity to morphine was not changed. The results show that all 11 phosphorylation sites contribute, in varying degrees, to acute desensitization and long-term tolerance. That acute desensitization and tolerance are not necessarily linked illustrates the complexity of events that are triggered by chronic treatment with morphine. SIGNIFICANCE STATEMENT: In this work, we showed that the degree of phosphorylation on the C terminus of the μ-opioid receptor alters acute desensitization and internalization, and in measures of long-term tolerance to morphine. The primary conclusion is that the degree of phosphorylation on the 11 possible sites of the C terminus has different roles for expression of the multiple adaptive mechanisms that follow acute and long-term agonist activation. Although the idea that acute desensitization and tolerance are intimately linked is generally supported, these results indicate that disruption of one phosphorylation cassette of the C terminus TSST (354-357) distinguishes the two processes.
Copyright © 2019 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31383769      PMCID: PMC6750191          DOI: 10.1124/mol.119.117358

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  20 in total

1.  Agonist Binding and Desensitization of the μ-Opioid Receptor Is Modulated by Phosphorylation of the C-Terminal Tail Domain.

Authors:  William T Birdsong; Seksiri Arttamangkul; James R Bunzow; John T Williams
Journal:  Mol Pharmacol       Date:  2015-05-01       Impact factor: 4.436

2.  Role of Phosphorylation Sites in Desensitization of µ-Opioid Receptor.

Authors:  Arsalan Yousuf; Elke Miess; Setareh Sianati; Yan-Ping Du; Stefan Schulz; MacDonald J Christie
Journal:  Mol Pharmacol       Date:  2015-05-12       Impact factor: 4.436

3.  Recovery from mu-opioid receptor desensitization after chronic treatment with morphine and methadone.

Authors:  Nidia Quillinan; Elaine K Lau; Michael Virk; Mark von Zastrow; John T Williams
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

Review 4.  Regulation of μ-opioid receptors: desensitization, phosphorylation, internalization, and tolerance.

Authors:  John T Williams; Susan L Ingram; Graeme Henderson; Charles Chavkin; Mark von Zastrow; Stefan Schulz; Thomas Koch; Christopher J Evans; Macdonald J Christie
Journal:  Pharmacol Rev       Date:  2013-01-15       Impact factor: 25.468

5.  Identification of two C-terminal amino acids, Ser(355) and Thr(357), required for short-term homologous desensitization of mu-opioid receptors.

Authors:  Hung-Li Wang; Wen-Teng Chang; Chia-Yu Hsu; Pei-Chen Huang; Yu-Wen Chow; Allen H Li
Journal:  Biochem Pharmacol       Date:  2002-07-15       Impact factor: 5.858

6.  Morphine desensitization and cellular tolerance are distinguished in rat locus ceruleus neurons.

Authors:  Erica S Levitt; John T Williams
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

7.  Desensitization of functional µ-opioid receptors increases agonist off-rate.

Authors:  John T Williams
Journal:  Mol Pharmacol       Date:  2014-04-18       Impact factor: 4.436

8.  ScanImage: flexible software for operating laser scanning microscopes.

Authors:  Thomas A Pologruto; Bernardo L Sabatini; Karel Svoboda
Journal:  Biomed Eng Online       Date:  2003-05-17       Impact factor: 2.819

9.  Cellular tolerance at the µ-opioid receptor is phosphorylation dependent.

Authors:  Seksiri Arttamangkul; Daniel A Heinz; James R Bunzow; Xianqiang Song; John T Williams
Journal:  Elife       Date:  2018-03-28       Impact factor: 8.140

10.  Phosphorylation-deficient G-protein-biased μ-opioid receptors improve analgesia and diminish tolerance but worsen opioid side effects.

Authors:  A Kliewer; F Schmiedel; S Sianati; A Bailey; J T Bateman; E S Levitt; J T Williams; M J Christie; S Schulz
Journal:  Nat Commun       Date:  2019-01-21       Impact factor: 17.694

View more
  10 in total

1.  Chronic Treatment with Morphine Disrupts Acute Kinase-Dependent Desensitization of GPCRs.

Authors:  Emily R Leff; Seksiri Arttamangkul; John T Williams
Journal:  Mol Pharmacol       Date:  2020-05-03       Impact factor: 4.436

Review 2.  Post-translational Modifications of Opioid Receptors.

Authors:  Mariana Lemos Duarte; Lakshmi A Devi
Journal:  Trends Neurosci       Date:  2020-04-16       Impact factor: 13.837

3.  Agonist-Specific Regulation of G Protein-Coupled Receptors after Chronic Opioid Treatment.

Authors:  Sweta Adhikary; Omar Koita; Joseph J Lebowitz; William T Birdsong; John T Williams
Journal:  Mol Pharmacol       Date:  2022-02-22       Impact factor: 4.054

4.  A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor.

Authors:  Renee A Bouley; Zara Y Weinberg; Helen V Waldschmidt; Yu-Chen Yen; Scott D Larsen; Manojkumar A Puthenveedu; John J G Tesmer
Journal:  Mol Pharmacol       Date:  2020-03-31       Impact factor: 4.436

Review 5.  Proteomic Approaches to Investigate Regulated Trafficking and Signaling of G Protein-Coupled Receptors.

Authors:  Mark von Zastrow
Journal:  Mol Pharmacol       Date:  2020-12-22       Impact factor: 4.436

Review 6.  Mechanisms of selective G protein-coupled receptor localization and trafficking.

Authors:  Jennifer M Kunselman; Joshua Lott; Manojkumar A Puthenveedu
Journal:  Curr Opin Cell Biol       Date:  2021-05-07       Impact factor: 8.386

7.  Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesia.

Authors:  Amanda Lillywhite; Stephen G Woodhams; Sara V Gonçalves; David J G Watson; Li Li; James J Burston; Peter R W Gowler; Meritxell Canals; David A Walsh; Gareth J Hathway; Victoria Chapman
Journal:  Pain Rep       Date:  2022-02-03

Review 8.  Side Effects of Opioids Are Ameliorated by Regulating TRPV1 Receptors.

Authors:  Xiaqing Wang; Chongyu Bao; Zhenjiang Li; Lupeng Yue; Li Hu
Journal:  Int J Environ Res Public Health       Date:  2022-02-18       Impact factor: 3.390

Review 9.  GRKs as Key Modulators of Opioid Receptor Function.

Authors:  Laura Lemel; J Robert Lane; Meritxell Canals
Journal:  Cells       Date:  2020-11-02       Impact factor: 6.600

Review 10.  Recent Progress in Opioid Research from an Electrophysiological Perspective.

Authors:  William T Birdsong; John T Williams
Journal:  Mol Pharmacol       Date:  2020-03-20       Impact factor: 4.436

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.